Hims sells all manner of pills, supplements, shampoos, sprays, and serums. Central to the Hims pitch is the fact that many people, especially younger men ... or side effect information” about ...

Erectile dysfunction (ED) is a common issue that affects millions of men, leading to a decline in quality of life and ...

T he ad that Hims & Hers Health plans to air during the Super Bowl comes at you with rapid-fire visual overload—a giant ...

The Super Bowl spot is a strikingly dark, politicized way of getting at the company’s latest initiative: selling weight-loss drugs to both women and men ... information” about an injectable ...

The content and links on www.NatLawReview.com are intended for general information purposes only ... legal or professional advice, kindly contact an attorney or other suitable professional ...

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

“Hims’ Super Bowl ad does not promote a specific drug or medication and therefore is not required to provide information about side effects or risks,” Brunner said in a statement.

Demand for discreet, convenient solutions in men's and women's health has always been there, waiting to be tapped. Part of what makes Hims "meme-worthy" is the viral-friendly nature of its offerings.

This information is key in gauging liquidity and interest levels for Hims & Hers Health's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest ...

Hims & Hers Health (NYSE: HIMS) is surging today. The stock is up 19%, and this is part of a broader 482.5% rally in the past year that has carried this telehealth company to nosebleed levels. Here’s ...